ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

July 2, 2004

UICC Announces Four Grant award Programs

July 14, 1978

In Brief: Comprehensive Centers “Jewel In Crown” Of Cancer Program, DeVita Says; Boutwell New NCAB Member

February 18, 1983

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

January 29, 2010

Groups’ Growth, Impact Shown by Five-Year Data

March 3, 1978

NCI reassigns project officer John Gohagan.

April 16, 2004